MUVON Therapeutics uses Drooms to finance further development of novel therapy

How the Swiss biotech start-up used Drooms’ data room solution to drive its fundraising and partnering efforts.  To help finance phase two of their clinical study, MUVON Therapeutics needed a solution to securely share confidential documents with potential investors. When the company engaged in its first large fundraising round, there was already a significant amount of fundraising documentation because the research had been running for a decade as a university project. The company used its private cloud to store and structure all its fundraising documents. Early on in the process, a Swiss advisor recommended MUVON Therapeutics use a data room for security reasons and recommended Drooms.

https://drooms.com/muvon-therapeutics-uses-drooms-to-finance-further-development-of-novel-therapy-download/

To access your free download, please fill out this form:

⭐ Whitepaper

By clicking "Download", I agree to be contacted by Drooms GmbH or Drooms AG via e-mail or telephone (if provided) to inform me about the company and its products in accordance with Drooms' privacy policy. I can revoke the consent at any time. Upon revocation, my data will no longer be processed for these purposes.

Discover other Drooms downloadables

White Paper

Real Estate Trends in 2024

Our transaction barometer provides detailed information on general sentiment in the real estate sector. What are the important developments on the European market overall? How do real estate markets differ in individual countries? And, what are the driving forces behind all of this?

Download

One data room. Many possibilities.

Due Diligence
Read More
Conduct proper due diligence for your M&A deal
Lifecycle management
Read More
Control and streamline asset documentation in your organisation
Document Analysis
Read More
Digitalise the document review phase
Digitisation
Read More
Get support with collecting, indexing, and digitising your documents
Fundraising
Read More



Conduct fundraising and share fund documents with potential investors
Previous
Next